$PMVP

$1.13 -$0.14 (11.02%) Close

$PMVP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 53.5M shares outstanding

Who owns PMVP?

By type of holder

Institutions 64.1% Insiders 10.7% Everyone else 25.2%

Concentration Top 10 holders own 51.0%

BML Capital Management, LLC 10.0% · Tang Capital Management LLC 7.9%

Institutional ownership

64.1%

-5.1 pts vs last qtr

Institutional holders

-6 vs last qtr

Net shares bought

−2.7M

by institutions in Q2 2026

New / sold out

3 / 9

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Adage Capital Partners GP, L.L.C. +500.0K
BIT Capital GmbH +284.0K

Biggest sellers in Q2 2026

ArrowMark Colorado Holdings LLC −913.2K
Morgan Stanley −822.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Pmv Pharmaceuticals, Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+265.8%

+29.61% a year

Each share's claim on the business

−72.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $44.6M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years27% 3–5 years7% 1–3 years35% Under 1 year30%

Quarterly turnover

7.5%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting PMVP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BC BML Capital Management, LLC	5.3M	9.97%	+10.0K (+0.2%)	2024	4.1%
Shares held by quarter Peak holding5.3M (Q2'26) Change over 8 quarters+3.6M Share of the company9.970% BML Capital Management, LLC's full portfolio →
TC Tang Capital Management LLC	4.2M	7.94%	Unchanged	Q3 '25	0.3%
Shares held by quarter Peak holding4.9M (Q4'25) Change over 8 quarters+4.2M Share of the company7.940% Tang Capital Management LLC's full portfolio →

BML Capital Management, LLC

5.3M

% of company

9.97%

Change vs last qtr

+10.0K (+0.2%)

Held since

2024

Tang Capital Management LLC

4.2M

% of company

7.94%

Change vs last qtr

Unchanged

Held since

Q3 '25

28 more super investors behind a free account

See every manager holding Pmv Pharmaceuticals, Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PMVP on Form N-PORT; together they hold 8.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$1.99M	1.5M	2.78%	0.00%	June 30, 2026
MS Meridian Small Cap Growth Fund Meridian Fund Inc	$1.42M	1.1M	1.98%	0.52%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$1.99M

% of company

2.78%

% of the fund

0.00%

As of

June 30, 2026

Meridian Small Cap Growth Fund

Meridian Fund Inc

Position value

$1.42M

% of company

1.98%

% of the fund

0.52%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Pmv Pharmaceuticals, Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
MD Mack David Henry Insider	508.1K	0.95%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.950% Mack David Henry's insider activity →
TR Ticktin Robert Insider	98.7K	0.18%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.180% Ticktin Robert's insider activity →

Mack David Henry

Insider

508.1K

% of company

0.95%

Change vs last qtr

—

Held since

—

Ticktin Robert

Insider

98.7K

% of company

0.18%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Pmv Pharmaceuticals, Inc.

Comments